Chromophobe renal cell carcinoma (RCC): Oncological outcomes and prognostic factors in a large multicentre series

Alessandro Volpe, Giacomo Novara, Alessandro Antonelli, Roberto Bertini, Michele Billia, Giorgio Carmignani, Sergio Cosciani Cunico, Nicola Longo, Guido Martignoni, Andrea Minervini, Vincenzo Mirone, Alchiede Simonato, Carlo Terrone, Filiberto Zattoni, Vincenzo Ficarra, O. De Cobelli, G. Martorana, R. Schiavina, S. Corti, C. SimeoneM. Castelli, S. Cimino, V. Favilla, G. Morgia, C. Imbimbo, M. Carini, L. Masieri, S. Serni, F. Oneto, V. Varca, F. Rocco, C. Valotto, E. Costantini, M. Porena, A. Zucchi, S. Ciciliato, N. Lampropoulou, S. Siracusano, D. Fontana, P. Gontero, A. Tizzani, W. Artibani, M. Brunelli, F. Montorsi, G. Petralia, M. Roscigno, E. Strada

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: • To investigate cancer-related outcomes of chromophobe renal cell carcinoma (ChRCC) in a large multicentre dataset. • To determine prognostic factors for recurrence-free survival (RFS) and cancer-specific survival (CSS) for this RCC histological type. PATIENTS AND METHODS: • In all, 291 patients with ChRCC were identified from a multi-institutional retrospective database including 5463 patients who were surgically treated for RCC at 16 Italian academic centres between 1995 and 2007. • Univariable and multivariable Cox regression models were used to identify prognostic factors predictive of RFS and CSS after surgery for ChRCC. RESULTS: • At a median follow-up of 44 months, 25 patients (8.6%) had disease recurrence and 18 patients (6.2%) died from disease.• The 5-year RFS and CSS rates were 89.3% and 93%, respectively. • Gender ( P = 0.014), clinical T stage ( P = 0.017), pathological T stage ( P = 0.003), and sarcomatoid differentiation ( P = 0.032) were independent predictors of RFS at multivariable analysis. • For CSS, there was an independent prognostic role for gender ( P = 0.032) and T stage ( P = 0.019) among the clinical variables and for T stage ( P = 0.016), N/M stage ( P = 0.023), and sarcomatoid differentiation ( P = 0.015) among the pathological variables. CONCLUSIONS: • Patients with ChRCC have a low risk of tumour progression, metastasis, and cancer-specific death. • Patient gender, clinical and pathological tumour stage, and sarcomatoid differentiation are significant predictors of RFS and CSS for ChRCC.

Original languageEnglish
Pages (from-to)76-83
Number of pages8
JournalBJU International
Volume110
Issue number1
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Renal Cell Carcinoma
Survival
Recurrence
Neoplasms
Proportional Hazards Models
Survival Rate
Databases
Neoplasm Metastasis

Keywords

  • Carcinoma
  • Chromophobe
  • Nephrectomy
  • Prognosis
  • Renal cell

ASJC Scopus subject areas

  • Urology

Cite this

Chromophobe renal cell carcinoma (RCC) : Oncological outcomes and prognostic factors in a large multicentre series. / Volpe, Alessandro; Novara, Giacomo; Antonelli, Alessandro; Bertini, Roberto; Billia, Michele; Carmignani, Giorgio; Cosciani Cunico, Sergio; Longo, Nicola; Martignoni, Guido; Minervini, Andrea; Mirone, Vincenzo; Simonato, Alchiede; Terrone, Carlo; Zattoni, Filiberto; Ficarra, Vincenzo; De Cobelli, O.; Martorana, G.; Schiavina, R.; Corti, S.; Simeone, C.; Castelli, M.; Cimino, S.; Favilla, V.; Morgia, G.; Imbimbo, C.; Carini, M.; Masieri, L.; Serni, S.; Oneto, F.; Varca, V.; Rocco, F.; Valotto, C.; Costantini, E.; Porena, M.; Zucchi, A.; Ciciliato, S.; Lampropoulou, N.; Siracusano, S.; Fontana, D.; Gontero, P.; Tizzani, A.; Artibani, W.; Brunelli, M.; Montorsi, F.; Petralia, G.; Roscigno, M.; Strada, E.

In: BJU International, Vol. 110, No. 1, 07.2012, p. 76-83.

Research output: Contribution to journalArticle

Volpe, A, Novara, G, Antonelli, A, Bertini, R, Billia, M, Carmignani, G, Cosciani Cunico, S, Longo, N, Martignoni, G, Minervini, A, Mirone, V, Simonato, A, Terrone, C, Zattoni, F, Ficarra, V, De Cobelli, O, Martorana, G, Schiavina, R, Corti, S, Simeone, C, Castelli, M, Cimino, S, Favilla, V, Morgia, G, Imbimbo, C, Carini, M, Masieri, L, Serni, S, Oneto, F, Varca, V, Rocco, F, Valotto, C, Costantini, E, Porena, M, Zucchi, A, Ciciliato, S, Lampropoulou, N, Siracusano, S, Fontana, D, Gontero, P, Tizzani, A, Artibani, W, Brunelli, M, Montorsi, F, Petralia, G, Roscigno, M & Strada, E 2012, 'Chromophobe renal cell carcinoma (RCC): Oncological outcomes and prognostic factors in a large multicentre series', BJU International, vol. 110, no. 1, pp. 76-83. https://doi.org/10.1111/j.1464-410X.2011.10690.x
Volpe, Alessandro ; Novara, Giacomo ; Antonelli, Alessandro ; Bertini, Roberto ; Billia, Michele ; Carmignani, Giorgio ; Cosciani Cunico, Sergio ; Longo, Nicola ; Martignoni, Guido ; Minervini, Andrea ; Mirone, Vincenzo ; Simonato, Alchiede ; Terrone, Carlo ; Zattoni, Filiberto ; Ficarra, Vincenzo ; De Cobelli, O. ; Martorana, G. ; Schiavina, R. ; Corti, S. ; Simeone, C. ; Castelli, M. ; Cimino, S. ; Favilla, V. ; Morgia, G. ; Imbimbo, C. ; Carini, M. ; Masieri, L. ; Serni, S. ; Oneto, F. ; Varca, V. ; Rocco, F. ; Valotto, C. ; Costantini, E. ; Porena, M. ; Zucchi, A. ; Ciciliato, S. ; Lampropoulou, N. ; Siracusano, S. ; Fontana, D. ; Gontero, P. ; Tizzani, A. ; Artibani, W. ; Brunelli, M. ; Montorsi, F. ; Petralia, G. ; Roscigno, M. ; Strada, E. / Chromophobe renal cell carcinoma (RCC) : Oncological outcomes and prognostic factors in a large multicentre series. In: BJU International. 2012 ; Vol. 110, No. 1. pp. 76-83.
@article{276590f5ba824163b08c179452dce115,
title = "Chromophobe renal cell carcinoma (RCC): Oncological outcomes and prognostic factors in a large multicentre series",
abstract = "OBJECTIVES: • To investigate cancer-related outcomes of chromophobe renal cell carcinoma (ChRCC) in a large multicentre dataset. • To determine prognostic factors for recurrence-free survival (RFS) and cancer-specific survival (CSS) for this RCC histological type. PATIENTS AND METHODS: • In all, 291 patients with ChRCC were identified from a multi-institutional retrospective database including 5463 patients who were surgically treated for RCC at 16 Italian academic centres between 1995 and 2007. • Univariable and multivariable Cox regression models were used to identify prognostic factors predictive of RFS and CSS after surgery for ChRCC. RESULTS: • At a median follow-up of 44 months, 25 patients (8.6{\%}) had disease recurrence and 18 patients (6.2{\%}) died from disease.• The 5-year RFS and CSS rates were 89.3{\%} and 93{\%}, respectively. • Gender ( P = 0.014), clinical T stage ( P = 0.017), pathological T stage ( P = 0.003), and sarcomatoid differentiation ( P = 0.032) were independent predictors of RFS at multivariable analysis. • For CSS, there was an independent prognostic role for gender ( P = 0.032) and T stage ( P = 0.019) among the clinical variables and for T stage ( P = 0.016), N/M stage ( P = 0.023), and sarcomatoid differentiation ( P = 0.015) among the pathological variables. CONCLUSIONS: • Patients with ChRCC have a low risk of tumour progression, metastasis, and cancer-specific death. • Patient gender, clinical and pathological tumour stage, and sarcomatoid differentiation are significant predictors of RFS and CSS for ChRCC.",
keywords = "Carcinoma, Chromophobe, Nephrectomy, Prognosis, Renal cell",
author = "Alessandro Volpe and Giacomo Novara and Alessandro Antonelli and Roberto Bertini and Michele Billia and Giorgio Carmignani and {Cosciani Cunico}, Sergio and Nicola Longo and Guido Martignoni and Andrea Minervini and Vincenzo Mirone and Alchiede Simonato and Carlo Terrone and Filiberto Zattoni and Vincenzo Ficarra and {De Cobelli}, O. and G. Martorana and R. Schiavina and S. Corti and C. Simeone and M. Castelli and S. Cimino and V. Favilla and G. Morgia and C. Imbimbo and M. Carini and L. Masieri and S. Serni and F. Oneto and V. Varca and F. Rocco and C. Valotto and E. Costantini and M. Porena and A. Zucchi and S. Ciciliato and N. Lampropoulou and S. Siracusano and D. Fontana and P. Gontero and A. Tizzani and W. Artibani and M. Brunelli and F. Montorsi and G. Petralia and M. Roscigno and E. Strada",
year = "2012",
month = "7",
doi = "10.1111/j.1464-410X.2011.10690.x",
language = "English",
volume = "110",
pages = "76--83",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - Chromophobe renal cell carcinoma (RCC)

T2 - Oncological outcomes and prognostic factors in a large multicentre series

AU - Volpe, Alessandro

AU - Novara, Giacomo

AU - Antonelli, Alessandro

AU - Bertini, Roberto

AU - Billia, Michele

AU - Carmignani, Giorgio

AU - Cosciani Cunico, Sergio

AU - Longo, Nicola

AU - Martignoni, Guido

AU - Minervini, Andrea

AU - Mirone, Vincenzo

AU - Simonato, Alchiede

AU - Terrone, Carlo

AU - Zattoni, Filiberto

AU - Ficarra, Vincenzo

AU - De Cobelli, O.

AU - Martorana, G.

AU - Schiavina, R.

AU - Corti, S.

AU - Simeone, C.

AU - Castelli, M.

AU - Cimino, S.

AU - Favilla, V.

AU - Morgia, G.

AU - Imbimbo, C.

AU - Carini, M.

AU - Masieri, L.

AU - Serni, S.

AU - Oneto, F.

AU - Varca, V.

AU - Rocco, F.

AU - Valotto, C.

AU - Costantini, E.

AU - Porena, M.

AU - Zucchi, A.

AU - Ciciliato, S.

AU - Lampropoulou, N.

AU - Siracusano, S.

AU - Fontana, D.

AU - Gontero, P.

AU - Tizzani, A.

AU - Artibani, W.

AU - Brunelli, M.

AU - Montorsi, F.

AU - Petralia, G.

AU - Roscigno, M.

AU - Strada, E.

PY - 2012/7

Y1 - 2012/7

N2 - OBJECTIVES: • To investigate cancer-related outcomes of chromophobe renal cell carcinoma (ChRCC) in a large multicentre dataset. • To determine prognostic factors for recurrence-free survival (RFS) and cancer-specific survival (CSS) for this RCC histological type. PATIENTS AND METHODS: • In all, 291 patients with ChRCC were identified from a multi-institutional retrospective database including 5463 patients who were surgically treated for RCC at 16 Italian academic centres between 1995 and 2007. • Univariable and multivariable Cox regression models were used to identify prognostic factors predictive of RFS and CSS after surgery for ChRCC. RESULTS: • At a median follow-up of 44 months, 25 patients (8.6%) had disease recurrence and 18 patients (6.2%) died from disease.• The 5-year RFS and CSS rates were 89.3% and 93%, respectively. • Gender ( P = 0.014), clinical T stage ( P = 0.017), pathological T stage ( P = 0.003), and sarcomatoid differentiation ( P = 0.032) were independent predictors of RFS at multivariable analysis. • For CSS, there was an independent prognostic role for gender ( P = 0.032) and T stage ( P = 0.019) among the clinical variables and for T stage ( P = 0.016), N/M stage ( P = 0.023), and sarcomatoid differentiation ( P = 0.015) among the pathological variables. CONCLUSIONS: • Patients with ChRCC have a low risk of tumour progression, metastasis, and cancer-specific death. • Patient gender, clinical and pathological tumour stage, and sarcomatoid differentiation are significant predictors of RFS and CSS for ChRCC.

AB - OBJECTIVES: • To investigate cancer-related outcomes of chromophobe renal cell carcinoma (ChRCC) in a large multicentre dataset. • To determine prognostic factors for recurrence-free survival (RFS) and cancer-specific survival (CSS) for this RCC histological type. PATIENTS AND METHODS: • In all, 291 patients with ChRCC were identified from a multi-institutional retrospective database including 5463 patients who were surgically treated for RCC at 16 Italian academic centres between 1995 and 2007. • Univariable and multivariable Cox regression models were used to identify prognostic factors predictive of RFS and CSS after surgery for ChRCC. RESULTS: • At a median follow-up of 44 months, 25 patients (8.6%) had disease recurrence and 18 patients (6.2%) died from disease.• The 5-year RFS and CSS rates were 89.3% and 93%, respectively. • Gender ( P = 0.014), clinical T stage ( P = 0.017), pathological T stage ( P = 0.003), and sarcomatoid differentiation ( P = 0.032) were independent predictors of RFS at multivariable analysis. • For CSS, there was an independent prognostic role for gender ( P = 0.032) and T stage ( P = 0.019) among the clinical variables and for T stage ( P = 0.016), N/M stage ( P = 0.023), and sarcomatoid differentiation ( P = 0.015) among the pathological variables. CONCLUSIONS: • Patients with ChRCC have a low risk of tumour progression, metastasis, and cancer-specific death. • Patient gender, clinical and pathological tumour stage, and sarcomatoid differentiation are significant predictors of RFS and CSS for ChRCC.

KW - Carcinoma

KW - Chromophobe

KW - Nephrectomy

KW - Prognosis

KW - Renal cell

UR - http://www.scopus.com/inward/record.url?scp=84862293109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862293109&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2011.10690.x

DO - 10.1111/j.1464-410X.2011.10690.x

M3 - Article

C2 - 22044519

AN - SCOPUS:84862293109

VL - 110

SP - 76

EP - 83

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 1

ER -